Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parenteral Anesthetics: Overview

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Prodrugs

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Photic sneeze reflex: When light becomes lethal.

The American journal of emergency medicine·2026

Same author

Reader Comment Regarding Iatrogenic STEMI in a male trauma patient due to coronary artery compression by a left sided chest tube.

The American journal of emergency medicine·2025

Same author

MINOCA post-blood donation: Beyond volume loss.

The American journal of emergency medicine·2025

Same author

Development of squamous cell carcinoma at the bite sites several years following suspected cobra (<i>Naja naja</i>) envenomings.

Clinical toxicology (Philadelphia, Pa.)·2024

Same author

Snakebite-induced reversible cerebral vasoconstriction syndrome: Report of three cases.

Toxicon : official journal of the International Society on Toxinology·2024

Same author

Challenges in rescuing snakes to protect human lives and promote snake conservation in Tamil Nadu, India.

PLoS neglected tropical diseases·2024

Search research articles

Related Experiment Videos

Propofol's derivative: a potential drug for erectile dysfunction?

Shah Sweni¹, Ramachandran Meenakshisundaram, S Senthilkumaran

¹Department of General Medicine, Chennai Medical College Hospital and Research Centre, Irungalur, Trichy, India. sweni85@gmail.com

Medical Hypotheses

|August 2, 2011

Summary

Propofol, an anesthetic, may treat erectile dysfunction by affecting brain receptors and penile tissues. Further research is needed to confirm its therapeutic potential for erectile dysfunction.

Related Experiment Videos

Area of Science:

Neuroscience
Pharmacology
Urology

Background:

Propofol, an anesthetic, is known to induce priapism.
Erectile dysfunction (ED) is a common condition with various underlying mechanisms.
Understanding the pharmacological effects of propofol may offer insights into novel ED therapies.

Purpose of the Study:

To explore the potential central nervous system and local penile mechanisms of propofol.
To hypothesize how propofol or similar molecules could be utilized in treating erectile dysfunction.
To review existing literature on propofol's effects relevant to erectile function.

Main Methods:

A comprehensive literature search was conducted covering publications from 1976 to 2010.
Key terms related to propofol, central nervous system effects, penile mechanisms, and erectile dysfunction were used.
Identified mechanisms were analyzed and discussed.

Main Results:

Central nervous system effects include inhibition of serotonin and GABA-A receptors, facilitation of NMDA-mediated calcium response, and agonism of dopaminergic D2 receptors.
Penile tissue effects may involve increased nitric oxide (NO) synthesis, inhibition of thromboxane A2, and stimulation of K-ATP channels.
These actions collectively suggest a potential role in maintaining erections.

Conclusions:

Propofol exhibits multiple mechanisms in both the central nervous system and penile tissue that could contribute to erectile function.
The findings suggest that propofol or analogous compounds warrant investigation as potential therapeutic agents for erectile dysfunction.
Further clinical evaluation is necessary to ascertain the efficacy and safety of propofol-based ED therapies.